NCT00499616 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 176
- group Id
- BG001
- value
- 142
- group Id
- BG002
- value
- 89
- group Id
- BG003
- value
- 57
- group Id
- BG004
- value
- 464
- units
- Participants
- groups
- description
- 2 courses of initial chemotherapy (6 wks) - carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, filgrastim. Partial response (PR) to chemo go to observation. No PR: 2-6 additional courses of chemo (beginning course 3 - cyclophosphamide, etoposide, filgrastim, carboplatin, doxorubicin hydrochloride). No PR after additional chemotherapy proceed to retrieval chemo: cyclophosphamide and topotecan hydrochloride on days 1-5. Treatment with retrieval chemotherapy repeats every 21 days for up to 6 courses. Some patients may also undergo surgery.
- id
- BG000
- title
- Group 2 (Chemotherapy, Surgery)
- description
- 4 courses of initial chemo - carboplatin, cyclophosphamide, doxorubicin hydrochloride, filgrastim. Patients with a PR after chemo proceed to observation. No PR receive 2-4 additional courses of chemotherapy (beginning with course 5) - carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, filgrastim. No PR after additional chemo proceed to retrieval chemo - cyclophosphamide and topotecan hydrochloride. Some patients may also undergo surgery.
- id
- BG001
- title
- Group 3 (Chemotherapy, Surgery)
- description
- 8 courses of initial chemo - carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, filgrastim. Patients \< 12 months of age with stg 3, 4, or 4S disease who achieve a very good PR (VGPR) to chemo (with the exception of resolution of skin or liver metastases in stage 4S patients) proceed to observation. Patients 12-18 months of age with stg 3 or 4 who achieve VGPR proceed to isotretinoin therapy. No VGPR proceed to retrieval chemo - cyclophosphamide and topotecan hydrochloride. Some patients may also undergo surgery.
- id
- BG002
- title
- Group 4 (Chemotherapy, Surgery, Antineoplastic Therapy)
- description
- The no treatment group assignment patients may have received some treatment on ANBL0531 but they were not evaluable on this study due to being non-intermediate risk and hence did not receive a treatment assignment on ANBL0531. Surgery: With the exception of patients with INSS 4S disease, patients undergo surgery to remove as much of the primary tumor and involved lymph nodes as can safely be accomplished.
- id
- BG003
- title
- Non-intermediate Risk Enrolled on Intermediate Risk Trial
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 176
- group Id
- BG001
- value
- 142
- group Id
- BG002
- value
- 89
- group Id
- BG003
- value
- 57
- group Id
- BG004
- value
- 464
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 1.47
- value
- 1.23
- group Id
- BG001
- spread
- .89
- value
- .74
- group Id
- BG002
- spread
- .36
- value
- .60
- group Id
- BG003
- spread
- 1.83
- value
- 1.51
- group Id
- BG004
- spread
- 1.26
- value
- 0.99
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 70
- group Id
- BG001
- value
- 72
- group Id
- BG002
- value
- 49
- group Id
- BG003
- value
- 26
- group Id
- BG004
- value
- 217
- title
- Female
- measurements
- group Id
- BG000
- value
- 106
- group Id
- BG001
- value
- 70
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 31
- group Id
- BG004
- value
- 247
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 57
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 150
- group Id
- BG001
- value
- 109
- group Id
- BG002
- value
- 74
- group Id
- BG003
- value
- 49
- group Id
- BG004
- value
- 382
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 25
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 19
- title
- Asian
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 8
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 52
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 133
- group Id
- BG001
- value
- 92
- group Id
- BG002
- value
- 59
- group Id
- BG003
- value
- 40
- group Id
- BG004
- value
- 324
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 16
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 59
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 3
- title
- New Zealand
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 37
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 153
- group Id
- BG001
- value
- 131
- group Id
- BG002
- value
- 78
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 412
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 12
- title
- Australia
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 176
- group Id
- BG001
- value
- 142
- group Id
- BG002
- value
- 89
- group Id
- BG003
- value
- 57
- group Id
- BG004
- value
- 464
- units
- Participants
- groups
- description
- 2 courses of initial chemotherapy (6 wks) - carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, filgrastim. Partial response (PR) to chemo go to observation. No PR: 2-6 additional courses of chemo (beginning course 3 - cyclophosphamide, etoposide, filgrastim, carboplatin, doxorubicin hydrochloride). No PR after additional chemotherapy proceed to retrieval chemo: cyclophosphamide and topotecan hydrochloride on days 1-5. Treatment with retrieval chemotherapy repeats every 21 days for up to 6 courses. Some patients may also undergo surgery.
- id
- BG000
- title
- Group 2 (Chemotherapy, Surgery)
- description
- 4 courses of initial chemo - carboplatin, cyclophosphamide, doxorubicin hydrochloride, filgrastim. Patients with a PR after chemo proceed to observation. No PR receive 2-4 additional courses of chemotherapy (beginning with course 5) - carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, filgrastim. No PR after additional chemo proceed to retrieval chemo - cyclophosphamide and topotecan hydrochloride. Some patients may also undergo surgery.
- id
- BG001
- title
- Group 3 (Chemotherapy, Surgery)
- description
- 8 courses of initial chemo - carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, filgrastim. Patients \< 12 months of age with stg 3, 4, or 4S disease who achieve a very good PR (VGPR) to chemo (with the exception of resolution of skin or liver metastases in stage 4S patients) proceed to observation. Patients 12-18 months of age with stg 3 or 4 who achieve VGPR proceed to isotretinoin therapy. No VGPR proceed to retrieval chemo - cyclophosphamide and topotecan hydrochloride. Some patients may also undergo surgery.
- id
- BG002
- title
- Group 4 (Chemotherapy, Surgery, Antineoplastic Therapy)
- description
- The no treatment group assignment patients may have received some treatment on ANBL0531 but they were not evaluable on this study due to being non-intermediate risk and hence did not receive a treatment assignment on ANBL0531. Surgery: With the exception of patients with INSS 4S disease, patients undergo surgery to remove as much of the primary tumor and involved lymph nodes as can safely be accomplished.
- id
- BG003
- title
- Non-intermediate Risk Enrolled on Intermediate Risk Trial
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 176
- group Id
- BG001
- value
- 142
- group Id
- BG002
- value
- 89
- group Id
- BG003
- value
- 57
- group Id
- BG004
- value
- 464
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 1.47
- value
- 1.23
- group Id
- BG001
- spread
- .89
- value
- .74
- group Id
- BG002
- spread
- .36
- value
- .60
- group Id
- BG003
- spread
- 1.83
- value
- 1.51
- group Id
- BG004
- spread
- 1.26
- value
- 0.99
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 70
- group Id
- BG001
- value
- 72
- group Id
- BG002
- value
- 49
- group Id
- BG003
- value
- 26
- group Id
- BG004
- value
- 217
- title
- Female
- measurements
- group Id
- BG000
- value
- 106
- group Id
- BG001
- value
- 70
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 31
- group Id
- BG004
- value
- 247
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 57
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 150
- group Id
- BG001
- value
- 109
- group Id
- BG002
- value
- 74
- group Id
- BG003
- value
- 49
- group Id
- BG004
- value
- 382
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 25
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 19
- title
- Asian
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 8
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 52
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 133
- group Id
- BG001
- value
- 92
- group Id
- BG002
- value
- 59
- group Id
- BG003
- value
- 40
- group Id
- BG004
- value
- 324
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 16
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 59
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 3
- title
- New Zealand
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 37
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 153
- group Id
- BG001
- value
- 131
- group Id
- BG002
- value
- 78
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 412
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 12
- title
- Australia
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle